Biotechnology & Drug Development Research Laboratory, School of Pharmacy & Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia 6102.
Ther Deliv. 2020 Dec;11(12):791-805. doi: 10.4155/tde-2020-0082. Epub 2020 Nov 23.
Developing new delivery dosage forms with robust delivery and safety profiles remains a challenge to the pharmaceutical industry in terms of optimum gut absorption, consistent dosing and bioavailability; particularly for orally administered drugs that are poorly water soluble. Coenzyme Q10 is an example of a poorly water-soluble compound with low bioavailability, and significant inter-individual variation after oral administration; limiting its optimum efficacy, as a powerful antioxidant with significant promise in treating hearing disorders. Microencapsulation technology is one way to optimize drug bioavailability and absorption profile. One example is Ionic Gelation Vibrational Jet Flow techniques, using new encapsulating parameters to determine the nature of formed capsules. Bile acids are an example of an excipient that can be used to improve membrane permeability; and will be examined. This review addresses the applications of microencapsulation technology on oral delivery and efficacy profiles of poorly water-soluble drugs, focusing on Coenzyme Q10.
开发具有稳健的传递和安全特性的新型传递剂型对于制药行业来说仍然是一个挑战,尤其是对于口服药物,这些药物水溶性差,难以达到最佳的肠道吸收、一致的剂量和生物利用度。辅酶 Q10 就是一个水溶性差、生物利用度低、口服后个体间差异大的例子,限制了其作为一种具有强大抗氧化作用、在治疗听力障碍方面具有巨大潜力的药物的最佳疗效。微囊化技术是优化药物生物利用度和吸收特性的一种方法。其中一个例子是离子凝胶振动射流技术,该技术使用新的包封参数来确定形成的胶囊的性质。胆酸是一种可以用来提高膜通透性的赋形剂,将对此进行研究。本文综述了微囊化技术在口服传递和水溶性差的药物疗效方面的应用,重点介绍了辅酶 Q10。